Abeona Therapeutics (ABEO) Non Operating Interest Expenses (2015 - 2018)

Abeona Therapeutics' Non Operating Interest Expenses history runs 4 years deep, the most recent figure standing at $2000.0 for Q4 2018.

• On a quarterly basis, Non Operating Interest Expenses rose 100.0% year-over-year to $2000.0 in Q4 2018; TTM through Jun 2019 was $5000.0, a 44.44% decrease from a year earlier, with the FY2018 full-year figure at $11000.0, up 37.5% from the prior year.
• Non Operating Interest Expenses eased to $2000.0 in Q4 2018 per ABEO's latest filing, from $3000.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $3000.0 in Q2 2017 and bottomed at $1000.0 in Q3 2015.
• The 4-year median for Non Operating Interest Expenses is $2000.0 (2015), against an average of $2000.0.
• Across the five-year window, Non Operating Interest Expenses sank 50.0% in 2016 and jumped 200.0% in 2017, its largest moves.
• Year by year, Non Operating Interest Expenses stood at $2000.0 in 2015, then changed by 0.0% to $2000.0 in 2016, then sank by 50.0% to $1000.0 in 2017, then soared by 100.0% to $2000.0 in 2018.
• Per Business Quant, the three latest ABEO Non Operating Interest Expenses figures stand at $2000.0 (Q4 2018), $3000.0 (Q3 2018), and $3000.0 (Q2 2018).